StatCounter

2024年5月27日 星期一

Super soup

It is too bad that this is just the first dinner I am able to prepare for myself this year. It is too good that this is the best dinner I have this year. Super delicious, super nutritious. Yet the crazy thing is I feel sleepy after eating it. They all are common food indeed - dried mushroom, black fungus, cabbage, tomato, pucuk manis, chili, pepper powder, salt, olive oil, sesame oil, and water - none is toxic. Maybe I am just too satisfied with it? Anyway I understand sometimes normal times normal become abnormal, vice versa. That is called "chemical reaction" or "exceptional".

Serious thing, serious do. Tidur.

2024年5月23日 星期四

Unexplainable Coincidence

It is the school year-end that full with these and those, while there are the weekends that full with chores and chaos. Yet there have been several times after I talked to You, you occurred - these unexplainable coincidences have made me felt more comfortable. 

2024年5月17日 星期五

风轻云淡
云卷云舒

2024年5月16日 星期四

Sweet Dream

Sweet dream,
For it's a rainy night

所以千萬不要喪失勇敢信心
Therefore do not throw away your confidence

原來你們所需要的就是堅忍
For you have need of endurance

- Hebrews 10:35 &36

2024年5月11日 星期六

從頭開始

僅僅需要一個決定

2024年5月6日 星期一

Johor’s data centres

Johor’s data centres getting a boost from the Singapore factor; water, power remain bottleneck

https://www.channelnewsasia.com/asia/malaysia-johor-data-centres-nvidia-ytl-kulai-sedenak-sez-us-china-trade-war-4310496

2024年5月4日 星期六

Adverse events following COVID‐19 mRNA vaccines

Adverse events following COVID‐19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia

Since publishing successful clinical trial results of mRNA coronavirus disease 2019 (COVID‐19) vaccines in December 2020, multiple reports have arisen about cardiovascular complications following the mRNA vaccination. This study provides an in‐depth account of various cardiovascular adverse events reported after the mRNA vaccines' first or second dose including pericarditis/myopericarditis, myocarditis, hypotension, hypertension, arrhythmia, cardiogenic shock, stroke, myocardial infarction/STEMI, intracranial hemorrhage, thrombosis (deep vein thrombosis, cerebral venous thrombosis, arterial or venous thrombotic events, portal vein thrombosis, coronary thrombosis, microvascular small bowel thrombosis), and pulmonary embolism.

A total of 81 articles analyzed confirmed cardiovascular complications post‐COVID‐19 mRNA vaccines in 17,636 individuals and reported 284 deaths with any mRNA vaccine. Of 17,636 cardiovascular events with any mRNA vaccine, 17,192 were observed with the BNT162b2 (Pfizer−BioNTech) vaccine, 444 events with mRNA‐1273 (Moderna). Thrombosis was frequently reported with any mRNA vaccine (
n = 13,936), followed by stroke (n = 758), myocarditis (n = 511), myocardial infarction (n = 377), pulmonary embolism (n = 301), and arrhythmia (n = 254). Stratifying the results by vaccine type showed that thrombosis (80.8%) was common in the BNT162b2 cohort, while stroke (39.9%) was common with mRNA‐1273 for any dose. The time between the vaccination dosage and the first symptom onset averaged 5.6 and 4.8 days with the mRNA‐1273 vaccine and BNT162b2, respectively. The mRNA‐1273 cohort reported 56 deaths compared to the 228 with BNT162b2, while the rest were discharged or transferred to the ICU.

Available literature includes more studies with the BNT162b2 vaccine than mRNA‐1273. Future studies must report mortality and adverse cardiovascular events by vaccine types.
Source: 

Referecene: 
A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19


DETOX, please.